SIVmac239-2

Ref. 3D-PP45744

Informations sur le produit

• Nom: SIVmac239-2
• Synonymes: H-NSVLSGKKADELEKI-OH

Description

Peptide SIVmac239-2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using SIVmac239-2 include the following: Peptide selection by MHC class I molecules TNM Schumacher , MLH De Bruijn, LN Vernie, WM Kast - Nature, 1991 - nature.comhttps://www.nature.com/articles/350703a0 Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes T Wieprecht, M Dathe, M Beyermann, E Krause - Biochemistry, 1997 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bi9619987 Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting T Terada, M Iwai, S Kawakami, F Yamashita - Journal of controlled , 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365906000083 Antibacterial agents based on the cyclic d,l-alpha-peptide architecture S Fernandez-Lopez, HS Kim, EC Choi, M Delgado - Nature, 2001 - nature.comhttps://www.nature.com/articles/35086601 Protein-peptide interactions RL Stanfield, IA Wilson - Current opinion in structural biology, 1995 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0959440X9580015S A critical assessment of the synthesis and biological activity of p53/human double minute 2-stapled peptide inhibitors R Wallbrecher, P Chaca¹ne, S Ruetz - British Journal of , 2017 - Wiley Online Libraryhttps://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/bph.13834 Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR2)-activating peptides in the rat paw N Vergnolle , MD Hollenberg - British journal of , 1999 - Wiley Online Libraryhttps://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1038/sj.bjp.0702634 Structural determinants for activity of glucagon-like peptide-2 MP DaCambra, B Yusta, M Sumner-Smith, A Crivici - Biochemistry, 2000 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bi000497p Colorimetric assay for parallel detection of Cd 2+, Ni 2+ and Co 2+ using peptide-modified gold nanoparticles M Zhang , YQ Liu, BC Ye - Analyst, 2012 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2012/an/c1an15909g Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex. M Tsudo, RW Kozak, CK Goldman - Proceedings of the , 1986 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.83.24.9694 The peptide recognized by HLA-A68. 2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 KT Hogan, DP Eisinger, SB Cupp III, KJ Lekstrom - Cancer research, 1998 - AACRhttps://aacrjournals.org/cancerres/article-abstract/58/22/5144/504650 Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2 K Matsuzaki, K Sugishita, N Fujii, K Miyajima - Biochemistry, 1995 - ACS Publicationshttps://pubs.acs.org/doi/pdf/10.1021/bi00010a034 Modulation of magainin 2-lipid bilayer interactions by peptide charge K Matsuzaki, A Nakamura, O Murase, K Sugishita - Biochemistry, 1997 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bi961870p Peptide folding induces high and selective affinity of a linear and small beta-peptide to the human somatostatin receptor 4 K Gademann , T Kimmerlin, D Hoyer - Journal of medicinal , 2001 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jm010816q A proapoptotic peptide for the treatment of solid tumors JC Mai, Z Mi, SH Kim, B Ng, PD Robbins - Cancer research, 2001 - AACRhttps://aacrjournals.org/cancerres/article-abstract/61/21/7709/507941 Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists J Rivier, J Gulyas, D Kirby, W Low - Journal of medicinal , 2002 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jm0202122 Structural basis for Ca2+-dependent formation of ALG-2/Alix peptide complex: Ca2+/EF3-driven arginine switch mechanism H Suzuki, M Kawasaki, T Inuzuka, M Okumura - Structure, 2008 - cell.comhttps://www.cell.com/structure/pdf/S0969-2126(08)00302-X.pdf Peptide size selection by the major histocompatibility complex-encoded peptide transporter. F Momburg , J Roelse, GJ Hammerling - The Journal of , 1994 - rupress.orghttps://rupress.org/jem/article-abstract/179/5/1613/25058 Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonists F Cattaneo, M Parisi, R Ammendola - International journal of molecular , 2013 - mdpi.comhttps://www.mdpi.com/1422-0067/14/4/7193 Structure, measurement, and secretion of human glucagon-like peptide-2 B Hartmann, AH Johnsen, C aca˜rskov, K Adelhorst - Peptides, 2000 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S019697819900176X Activation of osteo-progenitor cells by a novel synthetic peptide derived from the bone morphogenetic protein-2 knuckle epitope A Saito , Y Suzuki, S Ogata, C Ohtsuki - Biochimica et Biophysica , 2003 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1570963903002358

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 1,630.87 g/mol
• Formule: C₇₀H₁₂₃N₁₉O₂₅